![]() |
UTHR | United Therapeutics Corp |
Pharmaceutical Preparations |
Book value per $ invested | $ 0.37 |
Leverage | 12.49% |
Market Cap | $ 17.4B |
PE | 14.67 |
Dividend Yield | 0.00% |
Profit | $ 1.2B |
Margin | 41.45% |
United Therapeutics Corporation, a biotechnology company, is dedicated to the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. The company is headquartered in Silver Spring, Maryland.